Navigation Links
Vermillion Announces Appointment of John Hamilton to Board of Directors
Date:4/10/2008

of directors on April 8, 2008.

"We would like to thank Judy for her leadership, expertise and contributions as a board member," said Page. "She has added significant value to Vermillion for the past 5 years and we wish her well in her future endeavors."

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

Forward Looking Statement:

This news release contains forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions and the risks and uncertainties discussed in Vermillion's latest Form 10-K and Vermillion's periodic reports on Form 10-Q and Form 8-K. These forward-looking statements are based on Vermillion's current expectations. Vermillion is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise. Forward-looking statements cannot be guaranteed and actual results may differ materially from Vermillion's current expectations. You are encouraged to read Vermillion's reports filed with the U.S. Securities and Exchange Commission, available at http://www.sec.gov.


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
2. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
3. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
4. Vermillion Announces Effectiveness of Reverse Stock Split
5. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
8. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
9. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
10. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
11. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...lso Visit Detroit , (Vocu...nch Ambassador for International Investment, and C..., , ,What: Ambassador Appia is available to meet ...ves adopted by France to further develop the finan... and development., , ,When: Available for Intervie...
(Date:11/24/2009).../PRNewswire-FirstCall/--DowAgroSciencesCanadaannou...sionofThompsonsLimitedofBlenheim,Ontario.Theadditi...rrentseedsbusinessasthecompanyanticipatestheintrod...sHerbicideTolerantTraitTechnologyincornin2012.Thet..."Thisacquisitionbringstogethertwostrongprogressive...
(Date:11/24/2009)...ployment grew by 29,000 jobs in October, and the ...th during the U.S. recession. However, clinics and... systems are coming closer to having to actually c...rs. , (Vocus) November 24... in October despite the shedding of jobs in most o...
(Date:11/24/2009)...-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopha...izingnovelpainmanagementtherapies,announcedtodayth...,isscheduledtopresentatthe21stAnnualPiperJaffrayHe...wYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTonn...vailabletorespondtoquestionsduringthepresentations...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...tech, Inc. (OTC,Bulletin Board: NZYM) has earned f... their outstanding accomplishments in environmenta... The Silver Awards are presented by,the Synthetic ... and,sponsored by ChemStewards, SOCMA,s EHS&S init...rate Synthetech,s level of commitment and progress...
...nuary 1, 2008 will mark the,ritualistic day of New...New,Year also brings added pressure to smokers as ...ing Ban., For those resolving to make 2008 the st...low-level laser therapy, is available. Laser Thera...a very successful aid in,helping individuals to qu...
...fers Patient Support and Financial Assistance ...SCO, Calif., Dec. 18 Actelion,Pharmaceuticals US,...nteractive(R) survey, showing that an overwhelming...eps find the patient support program valuable,and ...pertension (PAH) and,Tracleer have improved due to...
Other Biology Technology:Synthetech Earns National Recognition for Performance Improvement Program 2Synthetech Earns National Recognition for Performance Improvement Program 3Laser Therapy Gives Smokers Hope for Successful New Year's Resolution 2Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information 2Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information 3Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information 4
(Date:11/23/2009)...by the Wildlife Conservation Society says that wes...he Republic of Congopart of the "mother lode" of m...becoming increasingly threatened by growing humans...protection of the swamp forests adjacent to the so...ecent surveys confirmed that high densities of the...
(Date:11/23/2009)...ll. A new study provides "incontrovertible eviden...e island of Sumatra about 73,000 years ago defores...he epicenter, researchers report. , The volcano ...nto the atmosphere, leaving a crater (now the worl...long and 35 kilometers wide. Ash from the event ha...
(Date:11/23/2009)...ovember 16, 2009 -- A USDOE and USDA study conclud...opland, and cropland pasture could be converted fr...sses, such as switchgrass, from which biomass coul...nomically viable production of a perennial grass m...omass are removed annually is expected to require ...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 1ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 2ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 3Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 1Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 2Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 3Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 4AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD Related Sleep Disturbances 47601 1AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD Related Sleep Disturbances 47601 2AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD Related Sleep Disturbances 47601 3AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD Related Sleep Disturbances 47601 4AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD Related Sleep Disturbances 47601 5
...ts have figured out the fate of healthy protein wh...orm in yeast: The protein converts to the prion fo...rotein goes bad. , This quick-change "mating" mane...ular machinery behind prions, infectious proteins ...sease and scrapie in animals and, in rare cases, C...
...e winning isolated battles, we could well lose the...ald ash borer in eastern Canada and the United Sta...llars in lost timber and ornamental trees, and dra...scape in eastern North America - with even more im...ished study is the first to document the invasive ...
...n interdisciplinary team of scientists in a multi-...most important food crops in Africa, cassava. , T...BioCassava Plus project as a recipient of one of t..." program grants. Created two years ago, the goal ...solutions to global health problems. , Leading the...
Other Biology News:Prions rapidly 'remodel' good protein into bad, Brown study shows 2Emerald Spectre haunts Ontario's ash forests 2Emerald Spectre haunts Ontario's ash forests 3Research team receives $7.5 million to study cassava 2
Bsu36 I from Promega
Multiskan EX from Thermo Scientific
Mouse Anti-Ubiquitin, Multi Monoclonal Antibody, Unconjugated, Clone FK2 from Assay Designs/Stressgen Bioreagents
T4 DNA Polymerase from Invitrogen
Biology Products: